Current Cancer Drug Targets,volume 10,issue 2  (01-2010)

Period of time： 2010年2期

Publisher： Bentham Science Publishers

Founded in： 2001

Total resources： 135

E-ISSN： 1873-5576|10|2

ISSN： 1568-0096

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Current Cancer Drug Targets,volume 10,issue 2

Menu

ROCK Inhibitors as Emerging Therapeutic Candidates for Sarcomas

Current Cancer Drug Targets,volume 10,issue 2 , Vol. 10, Iss. 2, 2010-03 , pp. 127-134

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Understanding FOXO, New Views on Old Transcription Factors

Current Cancer Drug Targets,volume 10,issue 2 , Vol. 10, Iss. 2, 2010-03 , pp. 135-146

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Pharmacological Modulation of Genome and Proteome Alterations in Mice Treated with the Endocrine Disruptor Bisphenol A

Current Cancer Drug Targets,volume 10,issue 2 , Vol. 10, Iss. 2, 2010-03 , pp. 147-154

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function

Current Cancer Drug Targets,volume 10,issue 2 , Vol. 10, Iss. 2, 2010-03 , pp. 155-167

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Ras-Induced Resistance to Lapatinib is Overcome by MEK Inhibition

Current Cancer Drug Targets,volume 10,issue 2 , Vol. 10, Iss. 2, 2010-03 , pp. 168-175

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation

Current Cancer Drug Targets,volume 10,issue 2 , Vol. 10, Iss. 2, 2010-03 , pp. 176-191

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors

Current Cancer Drug Targets,volume 10,issue 2 , Vol. 10, Iss. 2, 2010-03 , pp. 192-199

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Anti-GD2 Antibody Therapy for GD2-Expressing Tumors

Current Cancer Drug Targets,volume 10,issue 2 , Vol. 10, Iss. 2, 2010-03 , pp. 200-209

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Inhibitors of HDACs - Effective Drugs Against Cancer?

Current Cancer Drug Targets,volume 10,issue 2 , Vol. 10, Iss. 2, 2010-03 , pp. 210-228

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Antitumor Effect of Butanoylated Heparin with Low Anticoagulant Activity on Lung Cancer Growth in Mice and Rats

Current Cancer Drug Targets,volume 10,issue 2 , Vol. 10, Iss. 2, 2010-03 , pp. 229-241

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 11 item(s)